Outpatient adherence to beta-blocker therapy after acute myocardial infarction (Q34994513)

5 August 2017

Outpatient adherence to beta-blocker therapy after acute myocardial infarction (English)

1 reference

5 August 2017

myocardial infarction

1 reference

1

Javed Butler

1 reference

5 August 2017

7

Marie R Griffin

1 reference

5 August 2017

Patrick G Arbogast

2

1 reference

5 August 2017

Rhonda BeLue

3

1 reference

5 August 2017

James Daugherty

4

1 reference

5 August 2017

Manoj K Jain

5

1 reference

5 August 2017

Wayne A Ray

6

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Journal of the American College of Cardiology

5 August 2017

1 reference

5 August 2017

40

1 reference

5 August 2017

9

1 reference

5 August 2017

1589-1595

1 reference

Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Discontinuation of antihyperlipidemic drugs--do rates reported in clinical trials reflect rates in primary care settings?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Use of automated databases for pharmacoepidemiology research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Comparing Sources of Drug Data about the Elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Improving the quality of care for Medicare patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Changes in rates of beta-blocker use between 1994 and 1997 among elderly survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Are beta-blockers effective in elderly patients who undergo coronary revascularization after acute myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Beta-blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Quality of medical care delivered to Medicare beneficiaries: A profile at state and national levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Health and economic benefits of increased beta-blocker use following myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Predictors of medication adherence in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Medication compliance and older people: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

A qualitative study of increasing beta-blocker use after myocardial infarction: Why do some hospitals succeed?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

Beta-blocker dosages and mortality after myocardial infarction: data from a large health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902379-3

7 January 2021

10.1016/S0735-1097(02)02379-3

Identifiers

DOI

1 reference

5 August 2017

1 reference